Pain contributes substantially to reduced quality of life in individuals living with hidradenitis suppurativa (HS). Although improved understanding of HS pathogenesis and treatment has resulted in improved evidence-based HS management guidelines, comprehensive pain management guidelines have yet to be developed. Few HS-specific data exist to guide pharmacologic analgesia; however, recognizing HS pain as either acute or chronic and predominantly nociceptive (aching and gnawing pain due to tissue damage) versus neuropathic (burning-type pain due to somatosensory nervous system dysfunction) provides a conceptual framework for applying outside pain management practices to HS management. This article incorporates the best available evidence from the HS and pain literature to propose an HS pain algorithm that integrates psychological, pharmacologic, and complementary and alternative treatment modalities.

疼痛大大降低了化脓性汗腺炎 (HS) 患者的生活质量。尽管对 HS 发病机制和治疗的理解的提高导致了基于证据的 HS 管理指南的改进，但尚未制定全面的疼痛管理指南。很少有 HS 特异性数据可用于指导药物镇痛；然而，将 HS 疼痛识别为急性或慢性，主要是伤害性（由于组织损伤引起的疼痛和咬痛）与神经性（由于躯体感觉神经系统功能障碍引起的灼痛型疼痛）为将外部疼痛管理实践应用于 HS 管理提供了一个概念框架. 本文结合了 HS 和疼痛文献中可用的最佳证据，提出了一种 HS 疼痛算法，该算法整合了心理、药理学、